• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者移植神经元中的路易小体提示宿主到移植物的疾病传播。

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

作者信息

Li Jia-Yi, Englund Elisabet, Holton Janice L, Soulet Denis, Hagell Peter, Lees Andrew J, Lashley Tammaryn, Quinn Niall P, Rehncrona Stig, Björklund Anders, Widner Håkan, Revesz Tamas, Lindvall Olle, Brundin Patrik

机构信息

Neuronal Survival Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, 221 84 Lund, Sweden.

出版信息

Nat Med. 2008 May;14(5):501-3. doi: 10.1038/nm1746. Epub 2008 Apr 6.

DOI:10.1038/nm1746
PMID:18391963
Abstract

Two subjects with Parkinson's disease who had long-term survival of transplanted fetal mesencephalic dopaminergic neurons (11-16 years) developed alpha-synuclein-positive Lewy bodies in grafted neurons. Our observation has key implications for understanding Parkinson's pathogenesis by providing the first evidence, to our knowledge, that the disease can propagate from host to graft cells. However, available data suggest that the majority of grafted cells are functionally unimpaired after a decade, and recipients can still experience long-term symptomatic relief.

摘要

两名移植了胎儿中脑多巴胺能神经元且长期存活(11至16年)的帕金森病患者,其移植神经元中出现了α-突触核蛋白阳性的路易小体。据我们所知,我们的观察提供了首个证据,表明该疾病可从宿主细胞传播至移植细胞,这对于理解帕金森病的发病机制具有关键意义。然而,现有数据表明,十年后大多数移植细胞的功能并未受损,且接受者仍可长期缓解症状。

相似文献

1
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.帕金森病患者移植神经元中的路易小体提示宿主到移植物的疾病传播。
Nat Med. 2008 May;14(5):501-3. doi: 10.1038/nm1746. Epub 2008 Apr 6.
2
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.帕金森病长期胚胎黑质移植中的路易小体样病理改变。
Nat Med. 2008 May;14(5):504-6. doi: 10.1038/nm1747. Epub 2008 Apr 6.
3
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.12 岁和 16 岁纹状体间位脑桥内移植物中路易体病理学的特征,这些移植物在一名帕金森病患者中存活。
Mov Disord. 2010 Jun 15;25(8):1091-6. doi: 10.1002/mds.23012.
4
Research in motion: the enigma of Parkinson's disease pathology spread.动态研究:帕金森病病理传播之谜
Nat Rev Neurosci. 2008 Oct;9(10):741-5. doi: 10.1038/nrn2477. Epub 2008 Sep 4.
5
Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat.宿主来源的α 突触核蛋白向大鼠移植多巴胺能神经元的转移。
Neurobiol Dis. 2011 Sep;43(3):552-7. doi: 10.1016/j.nbd.2011.05.001. Epub 2011 May 12.
6
Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.帕金森病患者移植中分离的细胞损伤缺乏功能相关性。
J Neurol. 2009 Aug;256 Suppl 3:310-6. doi: 10.1007/s00415-009-5242-z.
7
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years.植入帕金森病患者体内的多巴胺神经元在无病理状态下存活了14年。
Nat Med. 2008 May;14(5):507-9. doi: 10.1038/nm1752. Epub 2008 Apr 6.
8
Non-autonomous cell death in Parkinson's disease.帕金森病中的非自主性细胞死亡。
Lancet Neurol. 2008 Jun;7(6):474-5. doi: 10.1016/S1474-4422(08)70099-1.
9
How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?如何提高移植到帕金森病模型中的胎儿腹侧中脑细胞的存活率?
Neurosci Bull. 2007 Nov;23(6):377-82. doi: 10.1007/s12264-007-0056-4.
10
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?帕金森病与α-突触核蛋白:帕金森病是否为类朊病毒疾病?
Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373.

引用本文的文献

1
Understanding the progression of Parkinson's disease: a review.了解帕金森病的进展:综述
BMJ Neurol Open. 2025 Sep 8;7(2):e001215. doi: 10.1136/bmjno-2025-001215. eCollection 2025.
2
Phase 1, randomized trials of MEDI1341: cerebrospinal fluid free α-synuclein lowered by >50.第一阶段,MEDI1341的随机试验:脑脊液游离α-突触核蛋白降低超过50 。
Brain Commun. 2025 Aug 19;7(5):fcaf304. doi: 10.1093/braincomms/fcaf304. eCollection 2025.
3
Monitoring and investigation to control the brain network disease under immunotherapy by using fractional operator.
利用分数阶算子对免疫治疗下的脑网络疾病进行监测与研究以实现控制。
Sci Rep. 2025 Aug 18;15(1):30161. doi: 10.1038/s41598-025-15307-y.
4
Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities.靶向α-突触核蛋白原纤维以减轻其病理活性的免疫球蛋白样结合物的设计。
Nat Commun. 2025 Aug 9;16(1):7368. doi: 10.1038/s41467-025-62755-1.
5
Impact of α-synuclein fibril structure on seeding activity in experimental models of Parkinson's disease.α-突触核蛋白纤维结构对帕金森病实验模型中种子活性的影响。
NPJ Parkinsons Dis. 2025 Jul 31;11(1):224. doi: 10.1038/s41531-025-01080-2.
6
Soluble and Insoluble Lysates from the Human A53T Mutant α-Synuclein Transgenic Mouse Model Induces α-Synucleinopathy Independent of Injection Site.来自人A53T突变α-突触核蛋白转基因小鼠模型的可溶性和不溶性裂解物可诱导α-突触核蛋白病,且与注射部位无关。
Int J Mol Sci. 2025 Jun 28;26(13):6254. doi: 10.3390/ijms26136254.
7
Human Pluripotent Stem Cell-Based Therapies for Parkinson's Disease: Challenges and Potential Solutions.基于人类多能干细胞的帕金森病治疗方法:挑战与潜在解决方案
Yonsei Med J. 2025 Jul;66(7):395-404. doi: 10.3349/ymj.2024.0447.
8
Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable.由患者来源并扩增的α-突触核蛋白聚集体诱导产生的细胞内包涵体在形态上无法区分。
Cells. 2025 May 9;14(10):684. doi: 10.3390/cells14100684.
9
Development of human targeted extracellular vesicles loaded with shRNA minicircles to prevent parkinsonian pathology.开发负载shRNA微环的人靶向细胞外囊泡以预防帕金森病病理。
Transl Neurodegener. 2025 May 26;14(1):26. doi: 10.1186/s40035-025-00484-7.
10
Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.用于治疗α-突触核蛋白病的单克隆α-突触核蛋白抗体amlenetug(Lu AF82422)的合理选择。
NPJ Parkinsons Dis. 2025 May 22;11(1):132. doi: 10.1038/s41531-024-00849-1.